Discover
Stocks
Consumer Goods
BMRN
BMRN
BioMarin Pharmaceutical Inc
90.11
0.03 (0.03%)
Delayed Prices By NASDAQ,
in USD
Market Closed
Invest
Buy
BMRN
BioMarin Pharmaceutical Inc
Overview
Stats
Chart
Analysis
News
Invest
Buy
FINANCIAL SUMMARY
For the quarter ended 31/12/2022, BioMarin Pharmaceutical Inc's revenues increased by 6.37% and amounted to 537.54M. Net income increased by 96.26% to -249.00K. Net assets increased by 0.76% to 4.60B and EPS increased from -0.04 to 0.00.
BMRN's Investor Relations
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Gross Margin
73.31%
Net Profit Margin
8.70%
Operating Margin
0.50%
Return On Investment
3.01%
Buy
S
89.99